In conclusion, this real‐world cohort study demonstrates that among patients with advanced non‐squamous NSCLC with PD‐L1 ≥ 50% and no targetable mutations, smoking status is a significant predictor of ICI treatment outcomes. This evidence concerns the gene CD274 and non-small cell lung carcinoma.